The weight-loss drug Wegovy lowers the risk of “adverse cardiovascular events” by 20%, according to data from a major trial shared by the drug’s maker Novo Nordisk Tuesday, causing the company’s shares to surge.
Various packages of the weight-loss drug "Wegovy" from the pharmaceutical company Novo Nordisk lie ... [+] on the sales counter in a Danish pharmacy.
In a press…